.

Phase 1

• Conditions: .; MedDRA version: 17.1Level: PTClassification code 10074555Term: Transplantation complicationSystem Organ Class: 10022117 - Injury, poisoning and procedural complications; Therapeutic area: Not possible to specify

• Registration Number: EUCTR2014-003544-12-FR
• Lead Sponsor: CHU de Clermont-Ferrand

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Study Start: 2015-01-06
• Last Update Posted: 8 January 2018

Recruitment & Eligibility

• Status: Authorised-recruitment may be ongoing or finished
• Sex: All
• Target Recruitment: 648

Inclusion Criteria

.
Are the trial subjects under 18? no
Number of subjects for this age range:
F.1.2 Adults (18-64 years) yes
F.1.2.1 Number of subjects for this age range 432
F.1.3 Elderly (>=65 years) yes
F.1.3.1 Number of subjects for this age range 216

Exclusion Criteria

.

Study & Design

• Study Type: Interventional clinical trial of medicinal product
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
Main Objective: .;Secondary Objective: .;Primary end point(s): .;Timepoint(s) of evaluation of this end point: .

Secondary Outcome Measures

Name	Time	Method
Secondary end point(s): .;Timepoint(s) of evaluation of this end point: .